EAVE II
EAVE II logo

Our Publications

See our findings in academic paper publications.

Quick Access List

A list of our academic paper publications without the detail

Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021 (EURO 2020)

July 2021: A research letter in The Lancet Digital Health models the impact of the Delta variant on COVID-19 cases, hospital admissions and deaths in Scotland around the time of EURO 2020.

Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study

July 2021: A paper published in The Lancet Digital Health describes the EAVE II platform and its use to monitor and forecast COVID-19 health outcomes across the Scottish population since March 2020.

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness

The Delta variant of COVID-19 is associated with approximately double the risk of hospitalisation compared with the Alpha variant, but vaccine continues to protect.

Cohort profile: Early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database

The EAVE II cohort profile, detailing why the cohort was set up, who is in the cohort, and what has been found, measured, and more.

Impact of COVID-19 Lockdown on the Incidence and Mortality of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: National Interrupted Time Series Analyses for Scotland and Wales

First national level analysis shows hospital admissions for COPD (Chronic Obstructive Pulmonary Disease) across Scotland and Wales fell during the first COVID-19 lockdown.

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.

EAVE II study of 2.53 million first COVID-19 vaccine doses across Scotland shows small increases in risk for some adverse events following Oxford-AstraZeneca vaccine.

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland

A milestone study, which points to the success of first dose mass vaccination in reducing COVID-19 hospitalisations across Scotland, is now available from The Lancet.

Pre-print of COVID-19 Vaccines Effectiveness in Scotland paper

Vaccination has been linked to a substantial reduction in the risk of Covid-19 admissions to Scotland’s hospitals, landmark research suggests in pre-print.

Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales

Study finds 36% fewer people were admitted to hospital in Scotland and Wales in the first lockdown due to asthma.

Impact of COVID-19 on accident and emergency attendances and admissions in Scotland

New study highlights disruptive impact of pandemic on non-COVID NHS care in Scotland

COVID-19 in Pregnancy in Scotland (COPS): protocol for an observational study using linked Scottish national data

A prospective cohort study using linked data describes the incidence of COVID-19 in pregnancy at population level.

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from COVID-19 in adults: national derivation and validation cohort study

A study to derive and validate a risk prediction algorithm to estimate hospital admission and mortality outcomes from COVID-19 in adults.

EAVE II Study Protocol

Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): Protocol for an Observational Study using Linked Scottish National Data